Archives
-
o2h Ventures Investment Spotlight – Revolutionising Prostate Cancer Treatment 30 January, 2025
-
o2h Ventures Makes an Investment in Atelerix, an Innovative Gel-Based Tech to Preserve Live Cells 29 January, 2025
-
o2h Ventures Invests in Revolver Therapeutics Revolutionising Childhood Cancer Treatment 10 December, 2024
-
o2h Ventures Wins Best EIS Investment Manager – Specialist at Growth Investor Awards 2024 01 December, 2024
-
o2h Ventures Portfolio Company ViaNautis Enters Strategic Collaboration Agreement with Eli Lilly to Accelerate Genetic Medicine Development 30 October, 2024
-
o2h Ventures, Third-Time Finalist in the Best EIS Manager Specialist at the Growth Investor Awards 2024 09 August, 2024
-
Proud Partner of the 30th Anniversary Event by EISA, celebrating three decades of Enterprise Investment Schemes (EIS) 06 August, 2024
-
From Biotech Chemist to Family Office to Biotech Pioneer – Sunil Shah’s Exciting Journey in Biotech 31 July, 2024
-
o2h Ventures Proud to be Shortlisted for the EISA Impact Award for a Second Year Running! 07 June, 2024
invest in the growth potential of UK life science & AI